Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Correlation of 68Ga-DOTATATE PET/CT SUV and Ki-67 in NETs
NCT02840149Phase 3Completed
- Sponsor
- Jewish General Hospital
- Start
- Oct 2019
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial, sponsored by Jewish General Hospital. Primary endpoint: Correlation between SUV on 68Ga-DOTATATE PET/CT with Ki-67 index in NET at 2 years. Started Oct 2019; status: completed.
Beyond the preview
Go deeper on NCT02840149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02840149.